Blog: Research

Cannabis-based medicines: Two drugs approved for NHS

11 November 2019

Source BBC: Two cannabis-based medicines, used to treat epilepsy and multiple sclerosis, have been approved for use by the NHS in England.

European drug regulator recommends restricted use of Lemtrada

11 November 2019

Source MS Trust: Lemtrada (alemtuzumab) should be restricted to people with highly active relapsing-remitting MS according to a review carried out by the European Medicines Agency's (EMA) drug safety committee.

Sativex cost-effective in final NICE guideline on cannabis-based medicines

11 November 2019

Source MS Trust: Sativex is a cost-effective treatment for people with MS spasticity according to new guidance published today by NICE(link is external). This reverses the decision made in draft guidance published earlier this year.

Immersion in virtual reality scenes of the Arctic helps to ease people's pain

11 November 2019

Source Medical Xpress: Watching immersive 360 videos of icy Arctic scenes helps to relieve intense burning pain and could hold hope for treating chronic pain, a small study has found.

Can standing frames improve mobility in progressive MS?

25 October 2019

Source MS Trust: This study set out to test the benefits of regular home-based standing combined with strengthening and balance exercises for people with progressive MS.

People with progressive MS with severe walking problems (122 people) were recruited through NHS clinics and therapy centres in Devon, Cornwall and East Anglia. One half were assigned to the standing frame group in addition to their standard care, the other half continued with standard care alone for 20 weeks....

The MS research that's offering me hope

8 October 2019

Source BBC: "I don't like to think of the future. It's such a big question mark. I just keep living in the present."Source BBC: "I don't like to think of the future. It's such a big question mark. I just keep living in the present."

Diabetes drug offers hope of new treatment for multiple sclerosis.

7 October 2019

Source The Guardian: Trial using rats showed the drug metformin repaired nerve damage caused by the disease.

Detailed Genetic Map Implicates Broad Immune Cell Involvement in MS, Reports Risk Variant in X Chromosome

3 October 2019

Source Multiple Sclerosis News Today: A new large-scale genetic map implicates broad immune system dysfunction in patients with multiple sclerosis (MS), suggests a key role of brain immune cells called microglia, and indicates an MS-related gene variant located in the X chromosome.

Altogether, the findings — the result of the largest reported study of MS to date — provide the basis for up to 48% of the heritability for this disease.

The study, “Multiple sclerosis genomic map...

A request from Kings College London

23 September 2019

Hello! I am a PhD Student at King’s College London, and my project is focused on investigating anxiety in Multiple Sclerosis.

European Committee for Treatment and Research In Multiple Sclerosis 2019

23 September 2019

Source MS Trust: The ECTRIMS (European Committee for Treatment and Research In Multiple Sclerosis) is the largest annual international conference devoted to basic and clinical research in multiple sclerosis. The 2019 meeting took place in Stockholm from 11 to 13 September.

Pages

Category

Archive